777 related articles for article (PubMed ID: 10733894)
41. The propeptide is not required to produce catalytically active neutral protease from Bacillus stearothermophilus.
Mansfeld J; Petermann E; Dürrschmidt P; Ulbrich-Hofmann R
Protein Expr Purif; 2005 Feb; 39(2):219-28. PubMed ID: 15642473
[TBL] [Abstract][Full Text] [Related]
42. On-column refolding purification and characterization of recombinant human interferon-lambda1 produced in Escherichia coli.
Li M; Huang D
Protein Expr Purif; 2007 May; 53(1):119-23. PubMed ID: 17194602
[TBL] [Abstract][Full Text] [Related]
43. [Prokaryotic expression, purification, refolding and biological assays of recombinant human interleukin 4 inclusion body].
Li J; Cui K; Wen J; Zhao Z; Chen P; Tian L; Kan B; Wen Y; Deng H; Fan L; Wei Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Aug; 24(4):866-9. PubMed ID: 17899762
[TBL] [Abstract][Full Text] [Related]
44. A rapid single-step purification method for human interferon-gamma from isolated Escherichia coli inclusion bodies.
Haelewyn J; De Ley M
Biochem Mol Biol Int; 1995 Dec; 37(6):1163-71. PubMed ID: 8747547
[TBL] [Abstract][Full Text] [Related]
45. Refolding and purification of the human secreted group IID phospholipase A2 expressed as inclusion bodies in Escherichia coli.
Fonseca RG; Ferreira TL; Ward RJ
Protein Expr Purif; 2009 Oct; 67(2):82-7. PubMed ID: 19376232
[TBL] [Abstract][Full Text] [Related]
46. Refolding, purification, and activation of miniplasminogen and microplasminogen isolated from E. coli inclusion bodies.
Medynski D; Tuan M; Liu W; Wu S; Lin X
Protein Expr Purif; 2007 Apr; 52(2):395-402. PubMed ID: 17126563
[TBL] [Abstract][Full Text] [Related]
47. On-column refolding of corticotropin-releasing factor receptor 1 extracellular domain by size exclusion chromatography.
Ersoy M; Matic S; Schmidt SR
Biomed Chromatogr; 2009 Oct; 23(10):1121-8. PubMed ID: 19404927
[TBL] [Abstract][Full Text] [Related]
48. [Renaturation, purification and antigenicity identification of recombinant protein of Cysticercus cellulosae expressed in Escherichia coli].
Zhang S; Jia W; Luo X; Jing Z; Wu G; Zheng Y; Guo A; Cai X
Sheng Wu Gong Cheng Xue Bao; 2008 Aug; 24(8):1490-5. PubMed ID: 18998557
[TBL] [Abstract][Full Text] [Related]
49. Enhanced levan production using chitin-binding domain fused levansucrase immobilized on chitin beads.
Chiang CJ; Wang JY; Chen PT; Chao YP
Appl Microbiol Biotechnol; 2009 Mar; 82(3):445-51. PubMed ID: 19018526
[TBL] [Abstract][Full Text] [Related]
50. [Advances in in vitro refolding of inclusion body proteins].
Fang M; Huang HL
Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):608-12. PubMed ID: 11910749
[TBL] [Abstract][Full Text] [Related]
51. Expression, purification, and refolding of a novel immunotoxin containing humanized single-chain fragment variable antibody against CTLA4 and the N-terminal fragment of human perforin.
Wan L; Zeng L; Chen L; Huang Q; Li S; Lu Y; Li Y; Cheng J; Lu X
Protein Expr Purif; 2006 Aug; 48(2):307-13. PubMed ID: 16584889
[TBL] [Abstract][Full Text] [Related]
52. Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent.
Upadhyay V; Singh A; Jha D; Singh A; Panda AK
Microb Cell Fact; 2016 Jun; 15():100. PubMed ID: 27277580
[TBL] [Abstract][Full Text] [Related]
53. Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis.
Afzal AJ; Lightfoot DA
Protein Expr Purif; 2007 Jun; 53(2):346-55. PubMed ID: 17287130
[TBL] [Abstract][Full Text] [Related]
54. Renaturation of Escherichia coli-derived recombinant human macrophage colony-stimulating factor.
Tran-Moseman A; Schauer N; De Bernardez Clark E
Protein Expr Purif; 1999 Jun; 16(1):181-9. PubMed ID: 10336876
[TBL] [Abstract][Full Text] [Related]
55. High pH solubilization and chromatography-based renaturation and purification of recombinant human granulocyte colony-stimulating factor from inclusion bodies.
Li M; Fan H; Liu J; Wang M; Wang L; Wang C
Appl Biochem Biotechnol; 2012 Mar; 166(5):1264-74. PubMed ID: 22212394
[TBL] [Abstract][Full Text] [Related]
56. A novel protein refolding method using a zeolite.
Chiku H; Kawai A; Ishibashi T; Takehara M; Yanai T; Mizukami F; Sakaguchi K
Anal Biochem; 2006 Jan; 348(2):307-14. PubMed ID: 16316618
[TBL] [Abstract][Full Text] [Related]
57. Expression, purification, and refolding of biologically active Acinetobacter baumannii OmpA from Escherichia coli inclusion bodies.
McConnell MJ; Pachón J
Protein Expr Purif; 2011 May; 77(1):98-103. PubMed ID: 21130880
[TBL] [Abstract][Full Text] [Related]
58. Expression, refolding, and characterization of a novel recombinant dual human stem cell factor.
Lu H; Zang Y; Ze Y; Zhu J; Chen T; Han J; Qin J
Protein Expr Purif; 2005 Oct; 43(2):126-32. PubMed ID: 16139754
[TBL] [Abstract][Full Text] [Related]
59. Use of the design-of-experiments approach for the development of a refolding technology for progenipoietin-1, a recombinant human cytokine fusion protein from Escherichia coli inclusion bodies.
Boyle DM; Buckley JJ; Johnson GV; Rathore A; Gustafson ME
Biotechnol Appl Biochem; 2009 Jul; 54(2):85-92. PubMed ID: 19435462
[TBL] [Abstract][Full Text] [Related]
60. Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli.
Rinas U; Hoffmann F; Betiku E; Estapé D; Marten S
J Biotechnol; 2007 Jan; 127(2):244-57. PubMed ID: 16945443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
